Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease
NCT06878131
·
clinicaltrials.gov ↗
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
BEHAVIORAL:
Colorectal Cancer
Sponsor
M.D. Anderson Cancer Center